New Zealand markets closed

Lixte Biotechnology Holdings, Inc. (8640.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-6.1000 (-100.00%)
As of 08:57AM CEST. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
4,203
5,353
4,824
5,069
-
Total cash
4,203
5,353
4,824
5,069
-
Other current assets
-
10.38
10.249
15
24.294
Total current assets
4,309
5,561
5,093
5,228
-
Non-current assets
Total non-current assets
0
0
0
0
-
Total assets
4,309
5,561
5,093
5,228
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
120.508
183.752
225.965
190.292
-
Accrued liabilities
-
-
-
10.467
0
Deferred revenues
157.1
165.022
76.961
15.765
-
Total current liabilities
313.858
395.756
302.926
216.524
-
Non-current liabilities
Total non-current liabilities
0
0
0
0
-
Total liabilities
313.858
395.756
302.926
216.524
-
Stockholders' equity
Common stock
3,500
3,500
3,501
3,501
-
Retained earnings
-48,482
-43,395
-37,082
-30,354
-
Total stockholders' equity
3,995
5,165
4,790
5,012
-
Total liabilities and stockholders' equity
4,309
5,561
5,093
5,228
-